Poland· PL-100121255
Sterko
A sabalis serrulatae fructus, inkl. kombinationspräparate product containing sabalis serrulatae fructus extractum spissum, registered in Poland by Glenmark Pharmaceuticals s.r.o.. The same ATC class is registered in 7 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Sabalis serrulatae fructus, inkl. kombinationspräparate is registered in 7 of 19 countries.
Countries holding a registration under ATC G04CX02 (sabalis serrulatae fructus, inkl. kombinationspräparate), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 5 of them publish a price we can compare per daily dose
Sabalis serrulatae fructus, inkl. kombinationspräparate · ATC G04CX02
7 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Netherlands
- Polandprice
- Switzerlandprice
The record
At a glance
URPL (Poland)- Active substance
- Sabalis serrulatae fructus extractum spissum
- Manufacturer
- Glenmark Pharmaceuticals s.r.o.
- Country
- Poland (PL)
- ATC code
- G04CX02
- ATC class
- Sabalis serrulatae fructus, inkl. Kombinationspräparate
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 3
- gtin05909991040710
- gtin05909991040727
- gtin05909991040734
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Sabalis serrulatae fructus, inkl. kombinationspräparate in 4 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesSABAL SERRxhomeo Private Limited d.b.a. Rxhomeo, Inc
- FinlandCurbisal
- BelgiumSabal Serrulata BoironBoiron
- NetherlandsSabal serrulataHeel Belgium n.v.
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Austria · Prostasan
- Belgium · Prosta-Urgenin
- France · Palmier De Floride Pharmatoka
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/dc37b268-b811-46e1-965c-1ab110ae58c5 GET /v1/drugs/dc37b268-b811-46e1-965c-1ab110ae58c5?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Kapsułki miękkie",
"source": "urpl",
"strength": "320 mg/kapsułkę",
"packaging": "05909991040710 ¦ OTC ¦ 22752\n30 kaps.\n05909991040727 ¦ OTC ¦ 22753\n60 kaps.\n05909991040734 ¦ OTC ¦ Skasowane ¦ 22754\n90 kaps.",
"substance": "Sabal serrulatae fructus extractum spissum 320 mg",
"common_name": "Sabalis serrulatae fructus extractum spissum",
"pl_product_id": "100121255",
"pozwolenie_nr": "10407",
"auth_procedure": "NAR",
"authorisation_validity": "Bezterminowe"
}See everything about sabalis serrulatae fructus, inkl. kombinationspräparate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.